Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Medical Sciences Division News

Nuffield Department of Clinical Neurosciences professors amongst first Group Leaders announced for new dedicated Parkinson's Research Centre

Professors Laura Parkkinen and Peter Magill have been appointed to UK DRI Group Leader roles.

Existing hospital analysers offer a low-cost method to screen for fake vaccines

An international team of researchers led by the University of Oxford and Oxford University Hospitals NHS Foundation Trust have demonstrated that hospital analysers can be used to identify fake liquid medical products.

'Hidden' costs of social care after a hip fracture exceed £1.25 billion a year in the UK

Social care for hip fracture costs the NHS over £1.25 billion, equating to £15K per patient every year, according to a new study by the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS).

New AI model could improve prediction of medium-term mortality in heart failure patients

Researchers from the University of Oxford and international collaborators have developed a new artificial intelligence model that can more accurately predict the medium-term risk of death for people with heart failure using routine electronic health records.

Epilepsy and the brain

Epilepsy is one of the most common neurological disorders, affecting roughly 50 million people around the world. Researchers at Oxford are looking at how epilepsy can be prevented, diagnosed and treated. Our experts are also raising awareness of the condition to reduce stigma and improve the quality of life for people with epilepsy, particularly those in under-resourced communities.